The Economic Times daily newspaper is available online now.

    Ambey Laboratories opens today: Check issue size, price band, GMP & other details

    Synopsis

    Ambey Laboratories’ SME IPO, aiming to raise Rs 44.68 crore by July 8, offers shares at Rs 65-68 in lots of 2,000. With Rs 100 crore revenue and Rs 6.02 crore profit, it's set to list on NSE SME.

    Ambey Laboratories opens today: Check issue size, price band, GMP & other detailsANI
    The SME IPO of Ambey Laboratories has opened for subscription today and will close on July 8. The company aims to raise about Rs 44.68 crore through the SME IPO and list the shares on NSE SME platform. Here are 10 key things investors need to know about the public offer before subscribing to the issue.

    1) About Ambey Laboratories

    Ambey Laboratories was established with a motive of carrying business activities in the chemical industry and a focus on crop protection to support the agricultural activities in our country. Besides this, Ambey carries on the activities in the field of manufacturing chemicals, compounds, herbal products, insecticides, pesticides and fungicides.

    2) Industry overview

    As per Chemexcil (Chemicals Export Promotion Council), India’s agrochemical export was estimated to be at $1.04 billion from April 2023-June 2023 (Provisional). The Indian colorants industry has emerged as a key player with a global market share of 15%.

    3) Ambey Laboratories IPO size

    The IPO is a combination of fresh equity sale of 62.58 lakh shares and an offer for sale of 3.12 lakh shares. Through the issue, the company plans to raise around Rs 44.68 crore.

    4) Ambey Laboratories IPO price band

    The company is offering its shares at Rs 65-68 apiece, and investors can bid for 2,000 shares in 1 lot.

    5) Ambey Laboratories financial performance

    For the period ended January 2024, the company clocked total revenues of Rs 100 crore and net profit of Rs 6.02 crore.

    Also Read: Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status

    6) Objects of the offer

    The net proceeds from the public offer will be used for working capital requirements, general corporate purposes and issue related expenses.

    7) Lead managers and Registrar

    Fast Track Finsec is acting as the lead manager to the issue and Link Intime India is the registrar.

    8) Issue structure

    About 50% of the offer is reserved for QIB investors, 35% for retail investors, and the rest 15% for non-institutional investors.

    9) Important dates

    The IPO opened on July 4 and will close on July 8. The final allotment will likely be made on July 9. The company's shares will likely get listed on July 11.

    10) Ambey Laboratories GMP

    Ahead of the issue opening, the company's shares were trading with a GMP of 22 in the unlisted marke


    (You can now subscribe to our ETMarkets WhatsApp channel)

    (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more

    (You can now subscribe to our ETMarkets WhatsApp channel)

    (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more
    The Economic Times

    Stories you might be interested in